“…173,187 Another approach to targeting the mitochondria of cancer cells is the development of a diverse group of compounds called delocalized lipophilic cations (DLCs). 195 These compounds, which include metal chelates, 196 are characterized by elevated partition coefficient values to readily pass lipid membranes and a delocalized positive charge, 197 which allows them to be driven towards negatively charged species. In fact, the mitochondria of cancer cells have elevated mitochondrial membrane potential (Δψ m ) due to an increased rate of ATP production.…”
Section: Antitumour Activity Of Gold(i) Compounds and Major Biological Targetsmentioning
This tutorial review highlights key principles underpinning the design of selected metallodrugs to target specific biological macromolecules (DNA and proteins). The review commences with a descriptive overview of the eukaryotic...
“…Researchers have synthesized F16 derivatives with substitutions in the indole ring of F16 to produce molecules with improved selectivity and antitumor activity, such as a 5BMF derivative that displays cytotoxic effects in vitro and antitumor effects in vivo. Furthermore, 5BMF has been useful as a fluorescent probe for tumor imaging capacity [ 97 ]. This molecule was complexed with human serum albumin (HSA) to form the 5BMF@HSA complex, which improved the fluorescence intensity of 5BMF and increased its solubility by nearly 3.4-fold.…”
Section: New Trojan Horses For Targeting Tumor Cell Mitochondriamentioning
confidence: 99%
“…Both 5BMF and 5BMF@HSA produced a decrease in subcutaneous U87MG tumors, but the complex showed slightly better tumor growth suppression than 5BMF group alone. Thus, the 5BMF@HSA complex has potential applications in both cellular imaging and antitumor therapeutics [ 97 ].…”
Section: New Trojan Horses For Targeting Tumor Cell Mitochondriamentioning
Interest in tumor cell mitochondria as a pharmacological target has been rekindled in recent years. This attention is due in part to new publications documenting heterogenous characteristics of solid tumors, including anoxic and hypoxic zones that foster cellular populations with differentiating metabolic characteristics. These populations include tumor-initiating or cancer stem cells, which have a strong capacity to adapt to reduced oxygen availability, switching rapidly between glycolysis and oxidative phosphorylation as sources of energy and metabolites. Additionally, this cell subpopulation shows high chemo- and radioresistance and a high capacity for tumor repopulation. Interestingly, it has been shown that inhibiting mitochondrial function in tumor cells affects glycolysis pathways, cell bioenergy, and cell viability. Therefore, mitochondrial inhibition may be a viable strategy for eradicating cancer stem cells. In this context, medicinal chemistry research over the last decade has synthesized and characterized “vehicles” capable of transporting novel or existing pharmacophores to mitochondrial tumor cells, based on mechanisms that exploit the physicochemical properties of the vehicles and the inherent properties of the mitochondria. The pharmacophores, some of which have been isolated from plants and others, which were synthesized in the lab, are diverse in chemical nature. Some of these molecules are active, while others are prodrugs that have been evaluated alone or linked to mitochondria-targeted agents. Finally, researchers have recently described drugs with well-proven safety and efficacy that may exert a mitochondria-specific inhibitory effect in tumor cells through noncanonical mechanisms. The effectiveness of these molecules may be improved by linking them to mitochondrial carrier molecules. These promising pharmacological agents should be evaluated alone and in combination with classic chemotherapeutic drugs in clinical studies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.